Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative concurrent radiotherapy with raltitrexed for gastric cancer
ChiCTR1900021702Phase 2Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltitrexed in gastric cancer (GC) and gastric adenocarcinoma, sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Efficacy of concurrent chemoradiation with raltitrexed. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
raltitrexed
03
Conditions
gastric cancer (GC)gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR1900021702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021702.